What do we know about benefits of H. pylori treatment in childhood?

被引:18
作者
Sierra, Monica S. [1 ]
Hastings, Emily V. [1 ]
Goodman, Karen J. [1 ]
机构
[1] Univ Alberta, Sch Publ Hlth, Ctr Excellence Gastrointestinal Inflammat & Immun, Dept Med,Dept Publ Hlth Sci, Edmonton, AB, Canada
关键词
benefit; child; Helicobacter pylori; prevention; treatment;
D O I
10.4161/gmic.27000
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Policy analysis shows that H. pylori test and treat strategies targeting adults at moderate to high risk of H. pylori-induced disease is likely to be cost-effective for preventing digestive diseases responsible for a large global disease burden. Little is known, however, about health benefits to children from eliminating this infection. We conducted a systematic review of the evidence regarding health benefits to children from treatment to eliminate H. pylori infection. We systematically searched Ovid MEDLINE for pertinent review articles published through 2012. We excluded reviews focused on treatment efficacy and scrutinized reference lists of selected reviews to identify additional eligible reviews. Fifteen reviews met specified inclusion criteria. Overall, they show that few reported studies investigating pediatric health effects of treatment for H. pylori infection were well designed with adequate statistical power. Thus, there is insufficient evidence for drawing conclusions about health benefits to children from treatment to eliminate H. pylori infection.
引用
收藏
页码:549 / 567
页数:19
相关论文
共 50 条
  • [41] Gastric cancer in Africa: what do we know about incidence and risk factors?
    Asombang, Akwi W.
    Kelly, Paul
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2012, 106 (02) : 69 - 74
  • [42] Pharmacological Prophylaxis of Venous Thromboembolism During Acute Phase of Spontaneous Intracerebral Hemorrhage: What Do We Know About Risks and Benefits?
    Masotti, Luca
    Godoy, Daniel Agustin
    Di Napoli, Mario
    Rabinstein, Alejandro A.
    Paciaroni, Maurizio
    Ageno, Walter
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (04) : 393 - 402
  • [43] Ebola: What do we need to know?
    Dinh, A.
    Severin, A.
    Havette, P.
    Peyrethon, C.
    Descatha, A.
    ARCHIVES DES MALADIES PROFESSIONNELLES ET DE L ENVIRONNEMENT, 2015, 76 (01) : 40 - 42
  • [44] Pathological Gambling - What Do We Know?
    Buchner, Ursula Gisela
    Wodarz, Norbert
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2011, 61 (08) : 341 - 346
  • [45] What do we really know about physical activity in obese children and adolescents?
    Frelut, ML
    Pérès, G
    CHILDHOOD OBESITY: FROM BASIC SCIENCES TO PUBLIC HEALTH, 2004, : 227 - 237
  • [46] Urease inhibitors for the treatment of H. pylori
    Guzel-Akdemir, Oezlen
    Akdemir, Atilla
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 35 (01) : 17 - 30
  • [47] What do we know now about evidence-based treatment for psychosis and aggressive behaviour or criminality that we did not know when community care was implemented?
    Hodgins, Sheilagh
    NORDIC JOURNAL OF PSYCHIATRY, 2024, 78 (08) : 649 - 658
  • [48] What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options
    Anuszkiewicz, Karolina
    Jankau, Jerzy
    Kur, Martyna
    BREAST CANCER, 2023, 30 (02) : 187 - 199
  • [49] Lipids and vascular disease: what we do and do not know
    Sniderman, AD
    Cianflone, K
    CLINICA CHIMICA ACTA, 1999, 286 (1-2) : 7 - 22
  • [50] Role of childhood infection in the sequelae of H. pylori disease
    Harris, Paul R.
    Smythies, Lesley E.
    Smith, Phillip D.
    Perez-Perez, Guillermo I.
    GUT MICROBES, 2013, 4 (06) : 426 - 438